Control of urine pH and its effect on sulfaethidole excretion in humans
HB Kostenbauder, JB Portnoff, JV Swintosky - Journal of Pharmaceutical …, 1962 - Elsevier
A technique is described whereby urine can be excreted by human subjects, at a pH near 5.0
or 8.0, with a variation of not more than 0.1 or 0.2 pH unit over periods of at least 15 hours. …
or 8.0, with a variation of not more than 0.1 or 0.2 pH unit over periods of at least 15 hours. …
In vitro release and in vivo penetration studies of a topical steroid from nonaqueous vehicles
RE Dempski, JB Portnoff… - Journal of Pharmaceutical …, 1969 - Wiley Online Library
A method is described for studying the in vitro release of dexamethasone and some of its
esters from gelled isopropyl myristate, petrolatum USP, and two other nonaqueous vehicles. …
esters from gelled isopropyl myristate, petrolatum USP, and two other nonaqueous vehicles. …
Cefoxitin sodium compatibility with intravenous infusions and additives
MJ O'Brien, JB Portnoff… - American Journal of …, 1979 - academic.oup.com
The compatibility and stability of cefoxitin sodium in solution with a series of frequently used
intravenous infusion fluids and injectable additives were studied. Cefoxitin sodium's stability …
intravenous infusion fluids and injectable additives were studied. Cefoxitin sodium's stability …
The development of sodium cefoxitin as a dosage form
JB Portnoff, MW Henley, FA Restaino - PDA Journal of …, 1983 - journal.pda.org
This paper traces the history of the development of Sterile Sodium Cefoxitin as a viable marketed
product. The effects of a number of physical and chemical parameters on the stability of …
product. The effects of a number of physical and chemical parameters on the stability of …
Preservation of sodium bisulfite in parenteral solutions of dexamethasone sodium phosphate
JB Portnoff, MW Henley, GP Polli - Bulletin of the Parenteral Drug …, 1973 - hero.epa.gov
IPA COPYRIGHT: ASHP A physical instability, encountered in a parenteral dexamethasone
sodium phosphate product which was demonstrated to be a function of sodium bisulfite …
sodium phosphate product which was demonstrated to be a function of sodium bisulfite …
[CITATION][C] Control of urine pH and its effect on drug excretion in humans.
P JB, S JV, K HB - Journal of Pharmaceutical Sciences, 1961 - europepmc.org
… PORTNOFF JB , … KOSTENBAUDER HB, PORTNOFF JB, SWINTOSKY JV …
[CITATION][C] Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
JB Portnoff, EM Cohen, MW Henley - Bulletin of the Parenteral Drug …, 1977 - europepmc.org
Development of parenteral and sterile ophthalmic suspensions--the R & D approach. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[HTML][HTML] What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa
SS Khalsa, LC Portnoff, D McCurdy-McKinnon… - Journal of eating …, 2017 - Springer
Background Relapse after treatment for anorexia nervosa (AN) is a significant clinical problem.
Given the level of chronicity, morbidity, and mortality experienced by this population, it is …
Given the level of chronicity, morbidity, and mortality experienced by this population, it is …
Time-scale modification of speech based on short-time Fourier analysis
M Portnoff - IEEE Transactions on Acoustics, Speech, and …, 1981 - ieeexplore.ieee.org
This paper develops the theoretical basis for time-scale modification of speech based on
short-time Fourier analysis. The goal is the development of a high-quality system for changing …
short-time Fourier analysis. The goal is the development of a high-quality system for changing …
[CITATION][C] The processing of small volume parenterals and related sterile products
RJ Harwood, JB Portnoff… - Pharmaceutical dosage …, 1993 - Marcel Dekker New York